Leiva, Maria Carmen
Gustafsson, Anna
Garre, Elena
Ståhlberg, Anders
Kovács, Anikó
Helou, Khalil
Landberg, Göran http://orcid.org/0000-0001-9004-9403
Funding for this research was provided by:
Cancerfonden (22-2080)
Vetenskapsrådet (2021-01008, 965065, 965580)
University of Gothenburg
Article History
Received: 16 October 2023
Accepted: 12 December 2023
First Online: 20 December 2023
Declarations
:
: All procedures were performed in accordance with the Declaration of Helsinki and approved by the Medical Faculty Research Ethics Committee (Regionala Etikprövningsnämnden) in Gothenburg (DNR: 515-12, S 164-02, and T972-18). Informed consent was obtained from all subjects involved in the study.
: A. Ståhlberg and G. Landberg are board members and shareholders of Iscaff Pharma AB. A. Ståhlberg is a board member and shareholder in SiMSen Diagnostics and Tulebovaasta. The approach to use patient-derived scaffolds is patented (WO 2018/083231 A1).